Olivia L Hulme1, Shaan Khurshid2, Lu-Chen Weng1, Christopher D Anderson3, Elizabeth Y Wang1, Jeffrey M Ashburner4, Darae Ko5, David D McManus6, Emelia J Benjamin7, Patrick T Ellinor8, Ludovic Trinquart9, Steven A Lubitz10. 1. Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts. 2. Cardiology Division, Massachusetts General Hospital, Boston, Massachusetts. 3. Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts; J.P. Kistler Stroke Research Center, Massachusetts General Hospital, Boston, Massachusetts. 4. Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts; Department of Medicine, Harvard Medical School, Boston, Massachusetts. 5. Department of Medicine, Boston University Medical Center, Boston, Massachusetts. 6. Departments of Medicine and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, Massachusetts. 7. Boston University and National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Massachusetts; Sections of Preventive Medicine and Cardiovascular Medicine, Department of Medicine, Boston University School of Medicine, and Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts. 8. Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts. 9. Boston University and National Heart, Lung, and Blood Institute Framingham Heart Study, Framingham, Massachusetts; Department of Biostatistics, Boston University School of Public Health, Boston, Massachusetts. 10. Cardiovascular Research Center, Massachusetts General Hospital, Boston, Massachusetts; Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, Massachusetts. Electronic address: slubitz@mgh.harvard.edu.
Abstract
OBJECTIVES: This study sought to determine whether the risk of atrial fibrillation AF can be estimated accurately by using routinely ascertained features in the electronic health record (EHR) and whether AF risk is associated with stroke. BACKGROUND: Early diagnosis of AF and treatment with anticoagulation may prevent strokes. METHODS: Using a multi-institutional EHR, this study identified 412,085 individuals 45 to 95 years of age without prevalent AF between 2000 and 2014. A prediction model was derived and validated for 5-year AF risk by using split-sample validation and model performance was compared with other methods of AF risk assessment. RESULTS: Within 5 years, 14,334 individuals developed AF. In the derivation sample (7,216 AF events of 206,042 total), the optimal risk model included sex, age, race, smoking, height, weight, diastolic blood pressure, hypertension, hyperlipidemia, heart failure, coronary heart disease, valvular disease, prior stroke, peripheral arterial disease, chronic kidney disease, hypothyroidism, and quadratic terms for height, weight, and age. In the validation sample (7,118 AF events of 206,043 total) the AF risk model demonstrated good discrimination (C-statistic: 0.777; 95% confidence interval [CI:] 0.771 to 0.783) and calibration (0.99; 95% CI: 0.96 to 1.01). Model discrimination and calibration were superior to CHARGE-AF (Cohorts for Heart and Aging Research in Genomic Epidemiology AF) (C-statistic: 0.753; 95% CI: 0.747 to 0.759; calibration slope: 0.72; 95% CI: 0.71 to 0.74), C2HEST (Coronary artery disease / chronic obstructive pulmonary disease; Hypertension; Elderly [age ≥75 years]; Systolic heart failure; Thyroid disease [hyperthyroidism]) (C-statistic: 0.754; 95% CI: 0.747 to 0.762; calibration slope: 0.44; 95% CI: 0.43 to 0.45), and CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Prior stroke, transient ischemic attack [TIA], or thromboembolism, Vascular disease, Age 65-74 years, Sex category [female]) scores (C-statistic: 0.702; 95% CI: 0.693 to 0.710; calibration slope: 0.37; 95% CI: 0.36 to 0.38). AF risk discriminated incident stroke (n = 4,814; C-statistic: 0.684; 95% CI: 0.677 to 0.692) and stroke within 90 days of incident AF (n = 327; C-statistic: 0.789; 95% CI: 0.764 to 0.814). CONCLUSIONS: A model developed from a real-world EHR database predicted AF accurately and stratified stroke risk. Incorporating AF prediction into EHRs may enable risk-guided screening for AF.
OBJECTIVES: This study sought to determine whether the risk of atrial fibrillation AF can be estimated accurately by using routinely ascertained features in the electronic health record (EHR) and whether AF risk is associated with stroke. BACKGROUND: Early diagnosis of AF and treatment with anticoagulation may prevent strokes. METHODS: Using a multi-institutional EHR, this study identified 412,085 individuals 45 to 95 years of age without prevalent AF between 2000 and 2014. A prediction model was derived and validated for 5-year AF risk by using split-sample validation and model performance was compared with other methods of AF risk assessment. RESULTS: Within 5 years, 14,334 individuals developed AF. In the derivation sample (7,216 AF events of 206,042 total), the optimal risk model included sex, age, race, smoking, height, weight, diastolic blood pressure, hypertension, hyperlipidemia, heart failure, coronary heart disease, valvular disease, prior stroke, peripheral arterial disease, chronic kidney disease, hypothyroidism, and quadratic terms for height, weight, and age. In the validation sample (7,118 AF events of 206,043 total) the AF risk model demonstrated good discrimination (C-statistic: 0.777; 95% confidence interval [CI:] 0.771 to 0.783) and calibration (0.99; 95% CI: 0.96 to 1.01). Model discrimination and calibration were superior to CHARGE-AF (Cohorts for Heart and Aging Research in Genomic Epidemiology AF) (C-statistic: 0.753; 95% CI: 0.747 to 0.759; calibration slope: 0.72; 95% CI: 0.71 to 0.74), C2HEST (Coronary artery disease / chronic obstructive pulmonary disease; Hypertension; Elderly [age ≥75 years]; Systolic heart failure; Thyroid disease [hyperthyroidism]) (C-statistic: 0.754; 95% CI: 0.747 to 0.762; calibration slope: 0.44; 95% CI: 0.43 to 0.45), and CHA2DS2-VASc (Congestive heart failure, Hypertension, Age ≥75 years, Diabetes mellitus, Prior stroke, transient ischemic attack [TIA], or thromboembolism, Vascular disease, Age 65-74 years, Sex category [female]) scores (C-statistic: 0.702; 95% CI: 0.693 to 0.710; calibration slope: 0.37; 95% CI: 0.36 to 0.38). AF risk discriminated incident stroke (n = 4,814; C-statistic: 0.684; 95% CI: 0.677 to 0.692) and stroke within 90 days of incident AF (n = 327; C-statistic: 0.789; 95% CI: 0.764 to 0.814). CONCLUSIONS: A model developed from a real-world EHR database predicted AF accurately and stratified stroke risk. Incorporating AF prediction into EHRs may enable risk-guided screening for AF.
Authors: M Lamassa; A Di Carlo; G Pracucci; A M Basile; G Trefoloni; P Vanni; S Spolveri; M C Baruffi; G Landini; A Ghetti; C D Wolfe; D Inzitari Journal: Stroke Date: 2001-02 Impact factor: 7.914
Authors: Katherine M Newton; Peggy L Peissig; Abel Ngo Kho; Suzette J Bielinski; Richard L Berg; Vidhu Choudhary; Melissa Basford; Christopher G Chute; Iftikhar J Kullo; Rongling Li; Jennifer A Pacheco; Luke V Rasmussen; Leslie Spangler; Joshua C Denny Journal: J Am Med Inform Assoc Date: 2013-03-26 Impact factor: 4.497
Authors: Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas Journal: Eur Heart J Date: 2016-08-27 Impact factor: 29.983
Authors: Leila H Borowsky; Susan Regan; Yuchiao Chang; Alison Ayres; Steven M Greenberg; Daniel E Singer Journal: Cerebrovasc Dis Date: 2017-02-17 Impact factor: 2.762
Authors: Moritz F Sinner; Katherine A Stepas; Carlee B Moser; Bouwe P Krijthe; Thor Aspelund; Nona Sotoodehnia; João D Fontes; A Cecile J W Janssens; Richard A Kronmal; Jared W Magnani; Jacqueline C Witteman; Alanna M Chamberlain; Steven A Lubitz; Renate B Schnabel; Ramachandran S Vasan; Thomas J Wang; Sunil K Agarwal; David D McManus; Oscar H Franco; Xiaoyan Yin; Martin G Larson; Gregory L Burke; Lenore J Launer; Albert Hofman; Daniel Levy; John S Gottdiener; Stefan Kääb; David Couper; Tamara B Harris; Brad C Astor; Christie M Ballantyne; Ron C Hoogeveen; Andrew E Arai; Elsayed Z Soliman; Patrick T Ellinor; Bruno H C Stricker; Vilmundur Gudnason; Susan R Heckbert; Michael J Pencina; Emelia J Benjamin; Alvaro Alonso Journal: Europace Date: 2014-07-18 Impact factor: 5.214
Authors: Loes C A Rutten-Jacobs; Renate M Arntz; Noortje A M Maaijwee; Henny C Schoonderwaldt; Lucille D Dorresteijn; Ewoud J van Dijk; Frank-Erik de Leeuw Journal: JAMA Date: 2013-03-20 Impact factor: 56.272
Authors: Matthew J Kolek; Amy J Graves; Meng Xu; Aihua Bian; Pedro Luis Teixeira; M Benjamin Shoemaker; Babar Parvez; Hua Xu; Susan R Heckbert; Patrick T Ellinor; Emelia J Benjamin; Alvaro Alonso; Joshua C Denny; Karel G M Moons; Ayumi K Shintani; Frank E Harrell; Dan M Roden; Dawood Darbar Journal: JAMA Cardiol Date: 2016-12-01 Impact factor: 14.676
Authors: Shaan Khurshid; Samuel Friedman; Christopher Reeder; Paolo Di Achille; Nathaniel Diamant; Pulkit Singh; Lia X Harrington; Xin Wang; Mostafa A Al-Alusi; Gopal Sarma; Andrea S Foulkes; Patrick T Ellinor; Christopher D Anderson; Jennifer E Ho; Anthony A Philippakis; Puneet Batra; Steven A Lubitz Journal: Circulation Date: 2021-11-08 Impact factor: 29.690
Authors: Shaan Khurshid; Nina Mars; Christopher M Haggerty; Qiuxi Huang; Lu-Chen Weng; Dustin N Hartzel; Kathryn L Lunetta; Jeffrey M Ashburner; Christopher D Anderson; Emelia J Benjamin; Veikko Salomaa; Patrick T Ellinor; Brandon K Fornwalt; Samuli Ripatti; Ludovic Trinquart; Steven A Lubitz Journal: Circ Genom Precis Med Date: 2021-08-31
Authors: Christopher D Anderson; Steven A Lubitz; Shaan Khurshid; Ludovic Trinquart; Lu-Chen Weng; Olivia L Hulme; Wyliena Guan; Darae Ko; Kristin Schwab; Natalia S Rost; Mostafa A Al-Alusi; Emelia J Benjamin; Patrick T Ellinor Journal: Stroke Date: 2020-04-07 Impact factor: 7.914
Authors: Shaan Khurshid; Uri Kartoun; Jeffrey M Ashburner; Ludovic Trinquart; Anthony Philippakis; Amit V Khera; Patrick T Ellinor; Kenney Ng; Steven A Lubitz Journal: Circ Arrhythm Electrophysiol Date: 2020-12-09
Authors: Aditya Bhat; Shaun Khanna; Henry H L Chen; Arnav Gupta; Gary C H Gan; A Robert Denniss; C Raina MacIntyre; Timothy C Tan Journal: Circ Cardiovasc Qual Outcomes Date: 2021-03-05
Authors: Shaan Khurshid; Samuel Friedman; James P Pirruccello; Paolo Di Achille; Nathaniel Diamant; Christopher D Anderson; Patrick T Ellinor; Puneet Batra; Jennifer E Ho; Anthony A Philippakis; Steven A Lubitz Journal: Circ Cardiovasc Imaging Date: 2021-06-15 Impact factor: 8.589
Authors: Ramesh Nadarajah; Jianhua Wu; Alejandro F Frangi; David Hogg; Campbell Cowan; Chris P Gale Journal: Eur Heart J Qual Care Clin Outcomes Date: 2022-06-06